Byron Hsu, Author at VectorLabs

Microglial Activation and Soluble TREM2 as a Potential Biomarker of Alzheimer’s Disease

Byron Hsu September 15, 2021

Since it was first described in 1906 by Alois Alzheimer, physicians and scientists have been searching for clues to the debilitating neurological condition Alzheimer’s disease (AD). To diagnose and treat the disease at its earliest stages, researchers are searching for additional biomarkers that can help guide our understanding of the disease.

Investigating Cross-Reactive Antibodies of SARS-CoV-2 with LIBRA-seq

Byron Hsu July 14, 2021

In this publication highlight, we review the use of LIBRA-seq to characterize monoclonal antibodies from a recovered SARS-CoV donor, expanding our understanding of cross-reactive antibodies for coronavirus.